Molina Healthcare, Inc. (MOH) vs Oscar Health, Inc. (OSCR)

A side-by-side comparison of Molina Healthcare, Inc. and Oscar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnMOH vs OSCR

growth of $100 · dividends reinvested · last 6y
MOH -8.4% (-1.4%/yr)OSCR -5.8% (-1.0%/yr)OSCR compounded faster over this window
050100150200Start $10020222023202420252026$92$94
MOH OSCR

MOH vs OSCR: by the numbers

  • MOH is the larger company ($10.48B vs $8.33B market cap).
  • OSCR trades at the lower trailing earnings multiple (22.95 vs 1056.84 P/E), one valuation lens rather than an overall verdict.
  • OSCR is profitable (3.60% net margin) while MOH runs a net loss (-0.02%).
  • OSCR grew revenue faster over the past five years (64.83% vs 13.56% CAGR).

Metrics side by side

Valuation

MetricMOHOSCR
P/E ratio1056.8422.95
Forward P/EN/A18.64
P/S ratio0.240.54
P/B ratio2.514.06
EV / EBITDA20.377.18
FCF yield2.57%52.04%

Profitability

MetricMOHOSCR
Gross margin13.07%14.38%
Operating margin0.66%4.07%
Net margin-0.02%3.60%
ROE-0.17%26.84%
ROIC3.56%22.98%

Growth (annualized)

MetricMOHOSCR
Revenue CAGR (5Y)13.56%64.83%
EPS CAGR (5Y)-4.78%N/A
FCF CAGR (5Y)-33.88%80.81%
Total return CAGR (5Y)-4.14%13.36%

Frequently asked

Which has the lower trailing P/E, MOH or OSCR?
OSCR has the lower trailing P/E: MOH trades at 1056.84 and OSCR at 22.95. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, MOH or OSCR?
Over the past five years, OSCR grew revenue faster — MOH at a 13.56% CAGR versus OSCR at 64.83%.
Is MOH or OSCR more profitable?
OSCR runs the higher net margin — MOH at -0.02% versus OSCR at 3.60%.
How have MOH and OSCR total returns compared?
Over the past 5 years, MOH delivered -4.14% and OSCR delivered 13.36% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.